{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioTech Nation ... with Dr. Moira Gunn","title":"Mark Litton, President & CEO, Athira Pharma","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/7b9f87ce\"></iframe>","width":"100%","height":180,"duration":1319,"description":"Alzheimer’s, Parkinson’s dementia, and other neurodegenerative diseases continue to be challenging, but now new science has led to a better understanding of the natural repair mechanisms in the brain. This, in turn, has generated new options for innovative treatments, and one such approach has entered late-stage human clinical trials. Dr. Mark Litton is the President and CEO of Athira Pharma. ","thumbnail_url":"https://img.transistorcdn.com/2O-bvNE3apnAmlMA6TtfHcDLDnv2fCS4nzWuofCE46M/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzMxMTgyLzE2NTM3/NjI1NzctYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}